ASCO 2023

ASCO 2026 Radioligand Therapy Advances Across Prostate CancerSent on 02 June 2026

ASCO 2026 Advancing Curative Strategies in Bladder and Kidney CancerSent on 01 June 2026

Key Prostate Cancer Insights From Day 3 at ASCOSent on 31 May 2026

ASCO 2026 Matching Prostate Cancer Treatment to Risk, Response, and Patient BenefitSent on 31 May 2026

Novel Approaches to Curing Bladder and Kidney Cancer at ASCO 2026Sent on 30 May 2026

Emerging RCC and Bladder Cancer Data From ASCO Day 1Sent on 30 May 2026

Key GU Oncology Data to Watch at ASCO 2026Sent on 26 May 2026

Extending Outcomes in mCRPC: Radioligand Therapy Strategies & Insights from ASCO 2025Sent on 05 June 2025

ASCO 2025: AI-Powered Precision in Prostate Cancer Risk Stratification—and MoreSent on 04 June 2025

ASCO 2025: Tracking mCRPC Progression and Treatment ResponseSent on 03 June 2025

From Perioperative to First-Line Advances and More: ASCO 2025 Bladder CancerSent on 02 June 2025

ASCO 2025 Biomarkers to Breakthroughs: Evolving Strategies in Renal Cell CarcinomaSent on 01 June 2025

ASCO 2025: Diagnostic & Treatment Advances in RCC and Urothelial CarcinomaSent on 31 May 2025

Starts Saturday: Expert-Led Written Coverage of ASCO 2025Sent on 28 May 2025

ASCO 2024 Prostate Cancer Rapid Oral Abstracts Conference HighlightsSent on 05 June 2024

ASCO 2024 Treatment Advances in Bladder and Renal Cell Carcinoma Sent on 04 June 2024

ASCO 2024 Advanced Prostate Cancer Trial UpdatesSent on 03 June 2024

ASCO 2024 Bladder and kidney Cancer Trial UpdatesSent on 03 June 2024

ASCO 2024 State-of-the-Art Diagnostic and Therapeutic Strategies in Renal Cell Carcinoma and Rapid Oral Abstract Coverage on Kidney and BladderSent on 02 June 2024

ASCO 2024 Treatment Advancements in Prostate Bladder and Kidney Cancer Sent on 01 June 2024

2024 ASCO and UroToday GU Oncology Conference Coverage Begins Friday May 31Sent on 29 May 2024

ASCO 2023 Prioritizing and Sequencing Therapy for Advanced Prostate Cancer and Management of Prostate Cancer in Older AdultsSent on 06 June 2023

ASCO 2023 Oral Abstract Session: Genitourinary Cancer--Kidney and Bladder Cancer and Prostate Cancer Poster Highlights Sent on 05 June 2023

ASCO 2023 Oral Abstract Highlights in Genitourinary Cancer--Prostate and TesticularSent on 05 June 2023

ASCO 2023 Enhancing Prostate Cancer Care: Innovations in Imaging, Treatment Intensification, and Systemic Therapy Optimization - Prostate Cancer Poster HighlightsSent on 04 June 2023

Highlights from ASCO 2023: Promising Findings in Prostate Cancer - Poster Session SummariesSent on 04 June 2023

ASCO 2023 Bladder Cancer Poster Session HighlightsSent on 03 June 2023

ASCO 2023 Time to Pain Progression by Disease Volume and Prostate Cancer Poster HighlightsSent on 03 June 2023

ASCO 2023 Renal Cell Carcinoma Poster Session HighlightsSent on 03 June 2023

What to Expect from UroToday Coverage at the Upcoming ASCO 2023 Annual Meeting Sent on 29 May 2023

Display #
Results 1 - 30 out of 30